1 (Image 1)
Pemetrexed Solution, Concentrate
Product Images NDC 0480-4516
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pemetrexed (NDC 0480-4516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
This is a chart of the Survival Probability for two groups of patients: the Pemetrexed treatment group and the Placebo group, which indicates the probability of survival for each group over time. The chart shows the number of patients at risk in each group, as well as their survival times in months.*
1 (Image 3)
1 (Image 4)
1 (Image 5)
The description is: "Survival probability graph for Pemetrexed B and Placebo over time in months. The number of patients at risk is also displayed for both groups at different time intervals."*
1 (Image 6)
Not available. The text seems to be a random collection of characters and symbols without any coherent meaning or structure.*
1 (Image 7)
1 (Image 8)
This text seems to be medical information about a drug called Pemetrexed Injection. It mentions that the drug needs to be diluted before intravenous infusion and should be used cautiously as it is a cytotoxic agent. The drug comes in a single-dose vial and needs to be discarded after use. The manufacturer of the drug is mentioned as Ters Pramacenicls and the drug is manufactured in Romania. The text also includes a caution for handling cytotoxic agents and provides instructions for dilution.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
